Clinically Relevant Benefits Seen for GLP-1RA, SGLTi Treatment of T1DM
Significant reductions seen in weight, HbA1c, total daily dose of insulin with GLP-1RA, and in HbA1c and basal insulin with SGLTi
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.